Claims for Patent: 9,827,242

Summary for Patent: 9,827,242

Title:	Method of treatment for mental disorders
Abstract:	The invention relates to a medicament or a method for treating mental disorders, in detail, ADHD comprising lurasidone, or a combination of lurasidone and a D.sub.4 receptor agonist.
Inventor(s):	Ikeda; Kazuhito (Osaka, JP), Ishiyama; Takeo (Osaka, JP)
Assignee:	SUMITOMO DAINIPPON PHARMA CO., LTD. (Osaka-shi, JP)
Application Number:	14/994,939
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,827,242
Patent Claims:	1. A method for improving attention function in schizophrenia and/or bipolar disorder which comprises administering a pharmaceutical composition comprising, as the sole active ingredient a therapeutically effective amount of lurasidone or a pharmaceutically acceptable acid addition salt thereof to a mammal in need thereof. 2. The method of claim 1 wherein the pharmaceutical composition is a tablet, wherein lurasidone or a pharmaceutically acceptable acid addition salt thereof is lurasidone hydrochloride and wherein the tablet is orally administered in a dosage of 20 mg to 160 mg per day. 3. The method of claim 1 wherein the attention function is attention function in bipolar disorder. 4. The method of claim 1 wherein the attention function is attention function in schizophrenia. 5. The method of claim 1 wherein improving attention function is one or more selected from the group consisting of improving impairment in continuous concentration, improving diminished rapid-reaction and improving reduced activity. 6. A method for improving attention function in schizophrenia and/or bipolar disorder which comprises administering a therapeutically effective amount of lurasidone or a pharmaceutically acceptable acid addition salt thereof as the sole active ingredient to a mammal in need thereof, wherein improving attention function is improving reduced activity.